These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8838877

  • 21. Comparison between sperm treated with pentoxifylline and 2-deoxyadenosine using hypo-osmotic swelling test.
    Laokirkkiat P, Kunathikom S, Choavaratana R, Petyim S, Prechapanich J.
    J Med Assoc Thai; 2007 Feb; 90(2):211-5. PubMed ID: 17375622
    [Abstract] [Full Text] [Related]

  • 22. Effects of pentoxifylline on sperm motion characteristics in normozoospermic men defined by a computer-aided sperm analysis.
    Kinutani M.
    Hiroshima J Med Sci; 1999 Dec; 48(4):117-21. PubMed ID: 10804985
    [Abstract] [Full Text] [Related]

  • 23. [Therapy of idiopathic astheno- and oligozoospermia with pentoxifylline].
    Schill WB.
    Fortschr Med; 1982 Apr 22; 100(15):696-700. PubMed ID: 7084857
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study.
    Safarinejad MR.
    Int Urol Nephrol; 2011 Jun 22; 43(2):315-28. PubMed ID: 20820916
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of pentoxifylline on immotile testicular spermatozoa.
    Taşdemir I, Taşdemir M, Tavukçuoğlu S.
    J Assist Reprod Genet; 1998 Feb 22; 15(2):90-2. PubMed ID: 9513848
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of human sperm motility.
    Wald M.
    J Urol; 2008 Aug 22; 180(2):442-3. PubMed ID: 18550108
    [No Abstract] [Full Text] [Related]

  • 34. L-carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility.
    Costa M, Canale D, Filicori M, D'lddio S, Lenzi A.
    Andrologia; 1994 Aug 22; 26(3):155-9. PubMed ID: 8085668
    [Abstract] [Full Text] [Related]

  • 35. World Health Organization grade 'a' motility and zona-binding test accurately predict IVF outcome for mild male factor and unexplained infertilities.
    Sifer C, Sasportes T, Barraud V, Poncelet C, Rudant J, Porcher R, Cedrin-Durnerin I, Martin-Pont B, Hugues JN, Wolf JP.
    Hum Reprod; 2005 Oct 22; 20(10):2769-75. PubMed ID: 15958402
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a cut-off value for sperm motility after different hours of incubation to select the suitable reproductive technology (IVF or ICSI).
    Zollner U, Martin S, Liebermann J, Steck T.
    Acta Obstet Gynecol Scand; 1999 Apr 22; 78(4):326-31. PubMed ID: 10203301
    [Abstract] [Full Text] [Related]

  • 37. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
    Farmakiotis D, Farmakis C, Rousso D, Kourtis A, Katsikis I, Panidis D.
    Fertil Steril; 2007 Oct 22; 88(4):847-53. PubMed ID: 17412336
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of the effect of the absence of sperm with rapid and linear progressive motility on subsequent pregnancy rates following intrauterine insemination or in vitro fertilization.
    Bollendorf A, Check JH, Lurie D.
    J Androl; 1996 Oct 22; 17(5):550-7. PubMed ID: 8957699
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.